FDA Approved: SKYCLARYS — Original Application (Biogen)

View source ↗

Summary

FDA approved SKYCLARYS (omaveloxolone) from Biogen under Original Application NDA216718 for the treatment of Friedreich's ataxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• SKYCLARYS (omaveloxolone)

Snippet

ORIG AP for SKYCLARYS (OMAVELOXOLONE)